Advanced Cardiac Therapeutics Studies Innovative Catheter System To Treat Arrythmias
Written on May 28, 2011
Headquartered in Laguna Beach, Calif., privately held Advanced Cardiac Therapeutics,Inc. specializes in advanced irrigated cardiac catheter ablation systems with proprietary temperature-sensing technology for the treatment of patients with cardiac arrhythmias.
The company recently announced that the first...
Rubigo Therapeutics Develops Early Assessment and Treatment for Skin Cancer
Written on May 25, 2011
There are multiple types of skin disorders that could cause anyone concerned about cancer to wonder about a spot on their skin or on a loved one’s skin. This fear of having cancer is not unfounded as the incidence of skin cancer is increasing at an alarming rate due in large part by ultraviolet (UV)...
Tianyin Pharmaceuticals Receives China’s SFDA Approval for Its Anti-Diabetic Drug Gliclazide
Written on May 24, 2011
Tianyin Pharmaceutical Co., Inc. (TPI)), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals has received China’s SFDA’s approval for its anti-diabetic drug Gliclazide...
Threshold Pharmaceuticals Selectively Targets Tumor Cells in Cancer Therapeutics
Written on May 24, 2011
Cancer, the second leading cause of death in the United States after cardiovascular disease, is a persisting problem that many talk about but few have yet to find effective treatments. The American Cancer Society estimates that 569,490 people died from cancer in the United States in 2010. Many cancers,...
BMEYE’s Heart Monitoring Technology May Set A New Standard In Patient Care
Written on May 23, 2011
During an average life span of 70 years, the human heart will pump more than 400 million litres of blood. Monitoring of the key cardiovascular parameters – blood pressure, cardiac output and oxygen delivery – can provide a practical, early warning of cardiovascular change and potential adverse...
Wound Management Technologies Addresses Multi Billion Dollar Wound Care Market With CellerateRX
Written on May 19, 2011
Wound Management Technologies, Inc., a rapidly growing provider of advanced biotech medical devices, and presenting company at OneMedForum NY 2011, recently announced the publication of an interview of its President Deborah Jenkins Hutchinson by CEOCFOInterviews.com, a weekly web publication consisting of...



